Rufo Humberto Lorente Poyatos
Rufo Humberto Lorente Poyatos
DIGESTIVE SYSTEM SPECIALIST
See more specialists on
Ciudad Realciudadreal
en/medical-staff/gastroenterologist
Dr. Rufo Humberto Lorente Poyatos holds a degree in Medicine and Surgery from Universidad Miguel Hernández (Alicante). He specialized in Gastroenterology through the MIR residency program at the Hospital Clínico Universitario San Cecilio in Granada between 1999 and 2003. He has worked as a Gastroenterologist since 2003 at the Hospital General Universitario de Ciudad Real. He completed doctoral coursework in Internal Medicine at the Universidad de Granada. He holds a Master's degree from ESADE Business School in Strategic Management in the Clinical Environment and a Master's degree from GETECCU in Inflammatory Bowel Disease. Among his scientific contributions, his participation in the GETECCU research group (Spanish Working Group on Crohn's Disease and Ulcerative Colitis) stands out, with numerous publications in national and international conferences and journals. He has also participated in clinical trials related to these diseases and the use of medications. He was head of the Inflammatory Bowel Disease Unit at the Hospital Gen.
Key information
- Award for best poster presentation on Inflammatory Bowel Disease2015
- Latest Publication:[An alternative therapy for endoscopic resolution of Buried Bumper Syndrome. The Pull-T Technique].
- Belongs to:GETECCU
Professional Details
Hospital Quirónsalud Ciudad Real
SPECIALIST PHYSICIAN DIGESTIVE SYSTEM
January 2000
Clínica Quirónsalud Alcázar
SPECIALIST PHYSICIAN DIGESTIVE SYSTEM
February 2025
Hospital Universitario Clínico San Cecilio
Resident Physician, Digestive System
June 1999
Study
Bachelor of Medicine and Surgery
University, Universidad Miguel Hernández de Elche
1998
Specialized Healthcare Training
Specialist in Digestive System
Healthcare Institutions
Another qualification
Doctoral course, 2nd cycle, Internal Medicine. Research proficiency
University
Bachelor of Medicine and Surgery
Semiology
Universidad de Castilla-La Mancha
October 2013
GETECCU / ENEIDA Study
Management and Long-term Outcomes of Crohns Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU
ENEIDA Registry Studies
EVODIS long-term study
CROHNEX study
EpidemIBD: Large-Scale Epidemiological Study of Inflammatory Bowel Disease in Spain
ADASCAL study
CAROUSEL study from GETECCU
[An alternative therapy for endoscopic resolution of Buried Bumper Syndrome. The Pull-T Technique].
Scientific article
[Eosinophilic enteritis as a rare cause of ascites].
Scientific article
[Predictive factors of eosinophilic esophagitis in esophageal food bolus impaction].
Scientific article
[Rectosigmoid endometriosis with lymph node involvement].
Scientific article
[Usefulness of self-expanding biodegradable prosthesis in the treatment of refractory benign stenosis: a case series study].
Scientific article
Anemia at the time of diagnosis of inflammatory bowel disease: Prevalence and associated factors in adolescent and adult patients.
Scientific article
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry.
Scientific article
Clinical features, therapeutic requirements and evolution of patients with Crohns disease and upper gastrointestinal involvement (CROHNEX study).
Scientific article
Clinical outcome after anti-tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long-term study.
Scientific article
Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU.
Scientific article
Effectiveness and safety of methotrexate monotherapy in patients with Crohns disease refractory to anti-TNF-a: results from the ENEIDA registry.
Scientific article
Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.
Scientific article
Effectiveness and safety of the switch from Remicade to CT-P13 in patients with inflammatory bowel disease.
Scientific article
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohns Disease: Real World Evidence From the ENEIDA Registry.
Scientific article
Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry.
Scientific article
Effects of anti-TNF-alpha therapy on hemoglobin levels and anemia in patients with inflammatory bowel disease.
Scientific article
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain.
Scientific article
Epidemiology and temporal trends (2000-2012) of inflammatory bowel disease in adult patients in a central region of Spain.
Scientific article
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
Scientific article
Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry.
Scientific article
Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry.
Scientific article
Fecal calprotectin is not superior to serum C-reactive protein or the Harvey-Bradshaw index in predicting postoperative endoscopic recurrence in Crohns disease.
Scientific article
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients.
Scientific article
Immunomodulatory Therapy Does Not Increase the Risk of Cancer in Persons With Inflammatory Bowel Disease and a History of Extracolonic Cancers.
Scientific article
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study.
Scientific article
Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study.
Scientific article
Management and Long-term Outcomes of Crohns Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU.
Scientific article
Preferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL study.
Scientific article
Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection.
Scientific article
Real-world short-term effectiveness of ustekinumab in 305 patients with Crohns disease: results from the ENEIDA registry.
Scientific article
Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry.
Scientific article
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naive Inflammatory Bowel Disease Patients.
Scientific article
Short and long?term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry.
Scientific article
Surgery for inflammatory bowel disease in Spain: How are we doing? Initial results of a nationwide prospective registry.
Scientific article
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA.
Scientific article
Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohns disease: Results from the ENEIDA registry.
Scientific article
GETECCU
Asociación Castellana de Aparato Digestivo (ACAD)
Sociedad Española de Patología Digestiva
Award for best poster presentation on Inflammatory Bowel Disease
Fundación Patología Digestiva
Make an appointment with this professional
Vídeos de
Consulta el contenido multimedia de este profesional.
Hospitals
Book an appointment now at one of our hospitals.
Hospital Quirónsalud Ciudad Real
C/ Alisos, 19
13002 Ciudad Real
Clínica Quirónsalud Alcázar
C/ Dr. J. González Merlo, s/n
13600 Alcázar de San Juan Ciudad Real
Articles on
Browse the latest articles on Tu canal de salud.
¿No tienes seguro de salud?
Con nuestros Planes de Salud Quirónsalud Connect tendrás un médico de medicina general todos los días las 24 horas. Y además gestor personal y medición facial de constantes vitales.